nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—SLCO1B3—Methotrexate—psoriatic arthritis	0.12	0.143	CbGbCtD
Rilpivirine—Glomerulonephritis membranous—Auranofin—psoriatic arthritis	0.0709	0.436	CcSEcCtD
Rilpivirine—SLCO1B1—Methotrexate—psoriatic arthritis	0.0698	0.0834	CbGbCtD
Rilpivirine—ABCG2—Dexamethasone—psoriatic arthritis	0.069	0.0824	CbGbCtD
Rilpivirine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0658	0.0786	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—psoriatic arthritis	0.0555	0.0662	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—psoriatic arthritis	0.0494	0.059	CbGbCtD
Rilpivirine—CYP2B6—Dexamethasone—psoriatic arthritis	0.0485	0.058	CbGbCtD
Rilpivirine—ABCB1—Betamethasone—psoriatic arthritis	0.0428	0.0511	CbGbCtD
Rilpivirine—ABCB1—Prednisolone—psoriatic arthritis	0.0422	0.0504	CbGbCtD
Rilpivirine—ABCB1—Prednisone—psoriatic arthritis	0.0399	0.0476	CbGbCtD
Rilpivirine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0394	0.0471	CbGbCtD
Rilpivirine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0308	0.0368	CbGbCtD
Rilpivirine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0299	0.0357	CbGbCtD
Rilpivirine—CYP3A4—Betamethasone—psoriatic arthritis	0.0256	0.0306	CbGbCtD
Rilpivirine—CYP3A4—Prednisolone—psoriatic arthritis	0.0253	0.0302	CbGbCtD
Rilpivirine—ABCB1—Dexamethasone—psoriatic arthritis	0.0249	0.0297	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—psoriatic arthritis	0.0239	0.0285	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—psoriatic arthritis	0.02	0.0239	CbGbCtD
Rilpivirine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0149	0.0178	CbGbCtD
Rilpivirine—Nephrotic syndrome—Auranofin—psoriatic arthritis	0.00883	0.0544	CcSEcCtD
Rilpivirine—Buffalo hump—Prednisone—psoriatic arthritis	0.00493	0.0303	CcSEcCtD
Rilpivirine—Adrenal insufficiency—Prednisone—psoriatic arthritis	0.00472	0.029	CcSEcCtD
Rilpivirine—Lipohypertrophy—Prednisone—psoriatic arthritis	0.00453	0.0279	CcSEcCtD
Rilpivirine—Opportunistic infection—Methylprednisolone—psoriatic arthritis	0.0031	0.0191	CcSEcCtD
Rilpivirine—Opportunistic infection—Dexamethasone—psoriatic arthritis	0.00282	0.0174	CcSEcCtD
Rilpivirine—Opportunistic infection—Betamethasone—psoriatic arthritis	0.00282	0.0174	CcSEcCtD
Rilpivirine—Depressed mood—Methylprednisolone—psoriatic arthritis	0.00279	0.0172	CcSEcCtD
Rilpivirine—Opportunistic infection—Prednisone—psoriatic arthritis	0.00246	0.0151	CcSEcCtD
Rilpivirine—Opportunistic infection—Methotrexate—psoriatic arthritis	0.00205	0.0126	CcSEcCtD
Rilpivirine—Decreased appetite—Auranofin—psoriatic arthritis	0.00132	0.00815	CcSEcCtD
Rilpivirine—Inflammation—Methylprednisolone—psoriatic arthritis	0.00129	0.00792	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00125	0.00766	CcSEcCtD
Rilpivirine—Abdominal pain—Auranofin—psoriatic arthritis	0.0012	0.00741	CcSEcCtD
Rilpivirine—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.00107	0.00659	CcSEcCtD
Rilpivirine—Diarrhoea—Auranofin—psoriatic arthritis	0.00104	0.00641	CcSEcCtD
Rilpivirine—Vomiting—Auranofin—psoriatic arthritis	0.000969	0.00596	CcSEcCtD
Rilpivirine—Rash—Auranofin—psoriatic arthritis	0.00096	0.00591	CcSEcCtD
Rilpivirine—Dermatitis—Auranofin—psoriatic arthritis	0.00096	0.0059	CcSEcCtD
Rilpivirine—Nausea—Auranofin—psoriatic arthritis	0.000905	0.00557	CcSEcCtD
Rilpivirine—Inflammation—Methotrexate—psoriatic arthritis	0.000852	0.00524	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.0008	0.00492	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000633	0.0039	CcSEcCtD
Rilpivirine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000567	0.00349	CcSEcCtD
Rilpivirine—Depression—Prednisone—psoriatic arthritis	0.000552	0.00339	CcSEcCtD
Rilpivirine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00055	0.00338	CcSEcCtD
Rilpivirine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000546	0.00336	CcSEcCtD
Rilpivirine—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000497	0.00306	CcSEcCtD
Rilpivirine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000463	0.00285	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000462	0.00284	CcSEcCtD
Rilpivirine—Depression—Methotrexate—psoriatic arthritis	0.000461	0.00284	CcSEcCtD
Rilpivirine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000456	0.0028	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—psoriatic arthritis	0.000455	0.0028	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—psoriatic arthritis	0.000449	0.00276	CcSEcCtD
Rilpivirine—Infection—Triamcinolone—psoriatic arthritis	0.000444	0.00273	CcSEcCtD
Rilpivirine—Infection—Methylprednisolone—psoriatic arthritis	0.000443	0.00272	CcSEcCtD
Rilpivirine—Insomnia—Prednisolone—psoriatic arthritis	0.000439	0.0027	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000437	0.00269	CcSEcCtD
Rilpivirine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000437	0.00269	CcSEcCtD
Rilpivirine—Mental disorder—Prednisone—psoriatic arthritis	0.000435	0.00268	CcSEcCtD
Rilpivirine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000433	0.00266	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—psoriatic arthritis	0.000432	0.00266	CcSEcCtD
Rilpivirine—Anxiety—Betamethasone—psoriatic arthritis	0.000421	0.00259	CcSEcCtD
Rilpivirine—Anxiety—Dexamethasone—psoriatic arthritis	0.000421	0.00259	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00041	0.00252	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000407	0.0025	CcSEcCtD
Rilpivirine—Insomnia—Triamcinolone—psoriatic arthritis	0.000404	0.00249	CcSEcCtD
Rilpivirine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000403	0.00248	CcSEcCtD
Rilpivirine—Infection—Betamethasone—psoriatic arthritis	0.000403	0.00248	CcSEcCtD
Rilpivirine—Infection—Dexamethasone—psoriatic arthritis	0.000403	0.00248	CcSEcCtD
Rilpivirine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000397	0.00245	CcSEcCtD
Rilpivirine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000397	0.00245	CcSEcCtD
Rilpivirine—Fatigue—Triamcinolone—psoriatic arthritis	0.000385	0.00237	CcSEcCtD
Rilpivirine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000384	0.00236	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000375	0.00231	CcSEcCtD
Rilpivirine—Anxiety—Prednisone—psoriatic arthritis	0.000367	0.00226	CcSEcCtD
Rilpivirine—Insomnia—Dexamethasone—psoriatic arthritis	0.000367	0.00226	CcSEcCtD
Rilpivirine—Insomnia—Betamethasone—psoriatic arthritis	0.000367	0.00226	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000366	0.00225	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000364	0.00224	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—psoriatic arthritis	0.000364	0.00224	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—psoriatic arthritis	0.000361	0.00222	CcSEcCtD
Rilpivirine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000352	0.00217	CcSEcCtD
Rilpivirine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000352	0.00217	CcSEcCtD
Rilpivirine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000352	0.00217	CcSEcCtD
Rilpivirine—Infection—Prednisone—psoriatic arthritis	0.000351	0.00216	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00035	0.00215	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00035	0.00215	CcSEcCtD
Rilpivirine—Fatigue—Dexamethasone—psoriatic arthritis	0.000349	0.00215	CcSEcCtD
Rilpivirine—Fatigue—Betamethasone—psoriatic arthritis	0.000349	0.00215	CcSEcCtD
Rilpivirine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000346	0.00213	CcSEcCtD
Rilpivirine—Skin disorder—Prednisone—psoriatic arthritis	0.000343	0.00211	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000331	0.00204	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000331	0.00204	CcSEcCtD
Rilpivirine—Dizziness—Prednisolone—psoriatic arthritis	0.000321	0.00198	CcSEcCtD
Rilpivirine—Asthenia—Triamcinolone—psoriatic arthritis	0.00032	0.00197	CcSEcCtD
Rilpivirine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00032	0.00197	CcSEcCtD
Rilpivirine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00032	0.00197	CcSEcCtD
Rilpivirine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00032	0.00197	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—psoriatic arthritis	0.000319	0.00196	CcSEcCtD
Rilpivirine—Decreased appetite—Prednisone—psoriatic arthritis	0.000307	0.00189	CcSEcCtD
Rilpivirine—Rash—Prednisolone—psoriatic arthritis	0.000306	0.00188	CcSEcCtD
Rilpivirine—Dermatitis—Prednisolone—psoriatic arthritis	0.000306	0.00188	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000306	0.00188	CcSEcCtD
Rilpivirine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000305	0.00188	CcSEcCtD
Rilpivirine—Fatigue—Prednisone—psoriatic arthritis	0.000304	0.00187	CcSEcCtD
Rilpivirine—Headache—Prednisolone—psoriatic arthritis	0.000304	0.00187	CcSEcCtD
Rilpivirine—Dizziness—Triamcinolone—psoriatic arthritis	0.000295	0.00182	CcSEcCtD
Rilpivirine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000295	0.00181	CcSEcCtD
Rilpivirine—Infection—Methotrexate—psoriatic arthritis	0.000293	0.0018	CcSEcCtD
Rilpivirine—Asthenia—Betamethasone—psoriatic arthritis	0.000291	0.00179	CcSEcCtD
Rilpivirine—Asthenia—Dexamethasone—psoriatic arthritis	0.000291	0.00179	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000289	0.00178	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000289	0.00178	CcSEcCtD
Rilpivirine—Nausea—Prednisolone—psoriatic arthritis	0.000288	0.00177	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—psoriatic arthritis	0.000287	0.00176	CcSEcCtD
Rilpivirine—Vomiting—Triamcinolone—psoriatic arthritis	0.000284	0.00175	CcSEcCtD
Rilpivirine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000283	0.00174	CcSEcCtD
Rilpivirine—Rash—Triamcinolone—psoriatic arthritis	0.000282	0.00173	CcSEcCtD
Rilpivirine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000281	0.00173	CcSEcCtD
Rilpivirine—Rash—Methylprednisolone—psoriatic arthritis	0.000281	0.00173	CcSEcCtD
Rilpivirine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000281	0.00173	CcSEcCtD
Rilpivirine—Headache—Triamcinolone—psoriatic arthritis	0.00028	0.00172	CcSEcCtD
Rilpivirine—Headache—Methylprednisolone—psoriatic arthritis	0.000279	0.00172	CcSEcCtD
Rilpivirine—Abdominal pain—Prednisone—psoriatic arthritis	0.000279	0.00172	CcSEcCtD
Rilpivirine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000277	0.00171	CcSEcCtD
Rilpivirine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000277	0.00171	CcSEcCtD
Rilpivirine—Dizziness—Betamethasone—psoriatic arthritis	0.000268	0.00165	CcSEcCtD
Rilpivirine—Dizziness—Dexamethasone—psoriatic arthritis	0.000268	0.00165	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—psoriatic arthritis	0.000267	0.00164	CcSEcCtD
Rilpivirine—Nausea—Triamcinolone—psoriatic arthritis	0.000265	0.00163	CcSEcCtD
Rilpivirine—Nausea—Methylprednisolone—psoriatic arthritis	0.000265	0.00163	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—psoriatic arthritis	0.000262	0.00161	CcSEcCtD
Rilpivirine—Vomiting—Dexamethasone—psoriatic arthritis	0.000258	0.00159	CcSEcCtD
Rilpivirine—Vomiting—Betamethasone—psoriatic arthritis	0.000258	0.00159	CcSEcCtD
Rilpivirine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000256	0.00158	CcSEcCtD
Rilpivirine—Rash—Dexamethasone—psoriatic arthritis	0.000256	0.00157	CcSEcCtD
Rilpivirine—Rash—Betamethasone—psoriatic arthritis	0.000256	0.00157	CcSEcCtD
Rilpivirine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000255	0.00157	CcSEcCtD
Rilpivirine—Dermatitis—Betamethasone—psoriatic arthritis	0.000255	0.00157	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000255	0.00157	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—psoriatic arthritis	0.000254	0.00156	CcSEcCtD
Rilpivirine—Headache—Dexamethasone—psoriatic arthritis	0.000254	0.00156	CcSEcCtD
Rilpivirine—Headache—Betamethasone—psoriatic arthritis	0.000254	0.00156	CcSEcCtD
Rilpivirine—Asthenia—Prednisone—psoriatic arthritis	0.000253	0.00156	CcSEcCtD
Rilpivirine—Diarrhoea—Prednisone—psoriatic arthritis	0.000241	0.00149	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000241	0.00148	CcSEcCtD
Rilpivirine—Nausea—Betamethasone—psoriatic arthritis	0.000241	0.00148	CcSEcCtD
Rilpivirine—Nausea—Dexamethasone—psoriatic arthritis	0.000241	0.00148	CcSEcCtD
Rilpivirine—Dizziness—Prednisone—psoriatic arthritis	0.000233	0.00144	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000233	0.00143	CcSEcCtD
Rilpivirine—Vomiting—Prednisone—psoriatic arthritis	0.000224	0.00138	CcSEcCtD
Rilpivirine—Rash—Prednisone—psoriatic arthritis	0.000223	0.00137	CcSEcCtD
Rilpivirine—Dermatitis—Prednisone—psoriatic arthritis	0.000222	0.00137	CcSEcCtD
Rilpivirine—Headache—Prednisone—psoriatic arthritis	0.000221	0.00136	CcSEcCtD
Rilpivirine—Asthenia—Methotrexate—psoriatic arthritis	0.000212	0.0013	CcSEcCtD
Rilpivirine—Nausea—Prednisone—psoriatic arthritis	0.00021	0.00129	CcSEcCtD
Rilpivirine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000202	0.00124	CcSEcCtD
Rilpivirine—Dizziness—Methotrexate—psoriatic arthritis	0.000195	0.0012	CcSEcCtD
Rilpivirine—Vomiting—Methotrexate—psoriatic arthritis	0.000188	0.00115	CcSEcCtD
Rilpivirine—Rash—Methotrexate—psoriatic arthritis	0.000186	0.00114	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—psoriatic arthritis	0.000186	0.00114	CcSEcCtD
Rilpivirine—Headache—Methotrexate—psoriatic arthritis	0.000185	0.00114	CcSEcCtD
Rilpivirine—Nausea—Methotrexate—psoriatic arthritis	0.000175	0.00108	CcSEcCtD
